Skip to main content
WINTECH NANO (SUZHOU) CO.,LTD. logo

WINTECH NANO (SUZHOU) CO.,LTD. — Investor Relations & Filings

Ticker · 688757 ISIN · CNE100007036 LEI · 300300PBGG600CFABG98 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 159 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688757

About WINTECH NANO (SUZHOU) CO.,LTD.

https://www.wintech-nano.com/

Wintech Nano (Suzhou) Co., Ltd. is a prominent independent third-party laboratory specializing in comprehensive analysis and testing services for the semiconductor and microelectronics sectors. The company provides a wide range of technical solutions, including Failure Analysis (FA), Material Analysis (MA), Reliability Testing (RT), and Circuit Editing (FIB). Equipped with advanced analytical instrumentation such as Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM), Wintech Nano supports clients across the integrated circuit supply chain, from design and wafer fabrication to packaging and assembly. The firm focuses on delivering high-precision diagnostic data and technical consultancy to accelerate product development cycles and enhance manufacturing yields. Its services are critical for quality control, process optimization, and root cause identification in complex electronic components and advanced materials.

Recent filings

Filing Released Lang Actions
关于召开2025年年度暨2026年第一季度业绩说明会的公告
Regulatory Filings Classification · 72% confidence The document is a public announcement by the company to convene a 2025 annual and 2026 Q1 performance explanation meeting (‘业绩说明会’). It does not contain the actual financial statements or results (they were previously published) nor is it the materials of an investor presentation or AGM. It simply announces the logistical details of an upcoming investor event. There is no category for a “performance explanation meeting notice” in the taxonomy, so this falls under the general regulatory announcement/fallback category: RNS.
2026-05-27 Chinese
董事会薪酬与考核委员会关于公司2026年限制性股票激励计划首次授予激励对象名单的核查意见（截止授予日）
Regulatory Filings Classification · 72% confidence The document is a formal announcement by the Board’s Remuneration and Appraisal Committee regarding the eligibility and approval of the initial grant list under a 2026 restricted stock incentive plan. It does not present financial statements or an earnings call transcript, nor is it an AGM presentation or a shareholder vote result. It is a routine regulatory disclosure about an equity incentive plan under Chinese securities rules, fitting the “Regulatory Filings” category (RNS) as a general compliance announcement rather than a direct capital issuance notice or a US-style remuneration proxy (DEF 14A).
2026-05-19 Chinese
第二届董事会第十六次会议决议公告
Board/Management Information Classification · 78% confidence The document is a corporate announcement of the resolutions passed at the company’s Second Board (Session 2) Sixteenth Meeting, detailing board meeting procedures, voting results, and approvals (e.g., exemption of notice period, stock incentive grant). This is neither a financial report nor a shareholder meeting vote, but rather a board meeting resolution announcement. This matches the Board/Management Information category (MANG).
2026-05-19 Chinese
上海市锦天城律师事务所关于胜科纳米（苏州）股份有限公司2026年限制性股票激励计划首次授予限制性股票之法律意见书
Regulatory Filings Classification · 32% confidence The document is a legal opinion letter issued by a law firm regarding the legality of a restricted stock incentive plan. It does not present financial statements, earnings data, management commentary, or an actual share issuance announcement. It is also not a U.S. proxy statement (DEF 14A), nor a full annual or interim report. Rather, it is a compliance/legal document provided for regulatory purposes. This does not neatly fit any other category, so it should be classified under the fallback Regulatory Filings (RNS).
2026-05-19 Chinese
华泰联合证券有限责任公司关于胜科纳米（苏州）股份有限公司2025年度持续督导跟踪报告
Regulatory Filings Classification · 90% confidence The document is a “持续督导跟踪报告” (continuous supervision follow-up report) prepared by the IPO sponsor (Huatai United Securities) for Shengke Nano, detailing issues found, risk analysis, financial indicators, use of IPO proceeds, shareholding changes, etc. It is a regulatory submission required by Chinese securities law following an initial public offering, not a standard annual or interim financial report, earnings release, or proxy/meeting material. It does not fit any more specific category, so it falls under the fallback “Regulatory Filings (RNS).”
2026-05-18 Chinese
上海市锦天城律师事务所关于胜科纳米（苏州）股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 78% confidence The document is a legal opinion letter (“法律意见书”) issued by Allbright Law Offices regarding the 2025 annual shareholders’ meeting procedures, qualifications, and vote validity of Shengke Nano (Suzhou) Co., Ltd. It is not the AGM materials or presentation itself (AGM-R), nor merely a voting results announcement (DVA), nor a standard corporate report (10-K, IR, ER, etc.), but rather a legal opinion accompanying the shareholder meeting. There is no specific category for legal opinion letters under the definitions provided. Therefore, this falls under the fallback category for miscellaneous regulatory submissions: Regulatory Filings (Code: RNS).
2026-05-18 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.